Abiraterone or Docetaxel Plus Androgen Deprivation in Hormone-Sensitive Prostate Cancer: More Questions Than Answers

被引：3

作者：

Aggarwal, Rahul ^{[1
]}

机构：

[1] Univ Calif San Francisco, Dept Med, Helen Diller Family Comprehens Canc Ctr, 1600 Divisadero St, San Francisco, CA 94143 USA

来源：

EUROPEAN UROLOGY | 2018年 / 73卷 / 06期

关键词：

OUTCOMES; THERAPY;

D O I：

10.1016/j.eururo.2017.10.028

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：845 / 846

页数：2

共 11 条

[1] Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer [J].

Annala, Matti ;

Struss, Werner J. ;

Warner, Evan W. ;

Beja, Kevin ;

Vandekerkhove, Gillian ;

Wong, Amanda ;

Khalaf, Daniel ;

Seppala, Irma-Liisa ;

So, Alan ;

Lo, Gregory ;

Aggarwal, Rahul ;

Small, Eric J. ;

Nykter, Matti ;

Gleave, Martin E. ;

Chi, Kim N. ;

Wyatt, Alexander W. .

EUROPEAN UROLOGY, 2017, 72 (01) :34-42

[2]

[Anonymous], 2011, NEW ENGL J MED

[3]

Fischer S, 2018, ANN ONCOL, V29

[4] Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer [J].

Fizazi, Karim ;

NamPhuong Tran ;

Fein, Luis ;

Matsubara, Nobuaki ;

Rodriguez-Antolin, Alfredo ;

Alekseev, Boris Y. ;

Ozguroglu, Mustafa ;

Ye, Dingwei ;

Feyerabend, Susan ;

Protheroe, Andrew ;

De Porre, Peter ;

Kheoh, Thian ;

Park, Youn C. ;

Todd, Mary B. ;

Chi, Kim N. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (04) :352-360

[5] Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial [J].

Gravis, Gwenaelle ;

Boher, Jean-Marie ;

Joly, Florence ;

Soulie, Michel ;

Albiges, Laurence ;

Priou, Franck ;

Latorzeff, Igor ;

Delva, Remy ;

Krakowski, Ivan ;

Laguerre, Brigitte ;

Rolland, Frederic ;

Theodore, Christine ;

Deplanque, Gael ;

Ferrero, Jean-Marc ;

Culine, Stephane ;

Mourey, Loic ;

Beuzeboc, Philippe ;

Habibian, Muriel ;

Oudard, Stephane ;

Fizazi, Karim .

EUROPEAN UROLOGY, 2016, 70 (02) :256-262

[6]

James N, 2017, ANN ONCOL, V28, pLBA34

[7] Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy [J].

James, N. D. ;

de Bono, J. S. ;

Spears, M. R. ;

Clarke, N. W. ;

Mason, M. D. ;

Dearnaley, D. P. ;

Ritchie, A. W. S. ;

Amos, C. L. ;

Gilson, C. ;

Jones, R. J. ;

Matheson, D. ;

Miliman, R. ;

Attard, G. ;

Chowdhury, S. ;

Cross, W. R. ;

Gillessen, S. ;

Parker, C. C. ;

Russell, J. M. ;

Berthold, D. R. ;

Brawley, C. ;

Adab, F. ;

Aung, S. ;

Birtle, A. J. ;

Bowen, J. ;

Brock, S. ;

Chakraborti, P. ;

Ferguson, C. ;

Gale, J. ;

Gray, E. ;

Hingorani, M. ;

Hoskin, P. J. ;

Lester, J. F. ;

Malik, Z. I. ;

McKinna, F. ;

McPhail, N. ;

Money-Kyrle, J. ;

O'Sullivan, J. ;

Parikh, O. ;

Protheroe, A. ;

Robinson, A. ;

Srihari, N. N. ;

Thomas, C. ;

Wagstaff, J. ;

Wylie, J. ;

Zarkar, A. ;

Parmar, M. K. B. ;

Sydes, M. R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (04) :338-351

[8] Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial [J].

James, Nicholas D. ;

Sydes, Matthew R. ;

Clarke, Noel W. ;

Mason, Malcolm D. ;

Dearnaley, David P. ;

Spears, Melissa R. ;

Ritchie, Alastair W. S. ;

Parker, Christopher C. ;

Russell, J. Martin ;

Attard, Gerhardt ;

de Bono, Johann ;

Cross, William ;

Jones, Rob J. ;

Thalmann, George ;

Amos, Claire ;

Matheson, David ;

Millman, Robin ;

Alzouebi, Mymoona ;

Beesley, Sharon ;

Birtle, Alison J. ;

Brock, Susannah ;

Cathomas, Richard ;

Chakraborti, Prabir ;

Chowdhury, Simon ;

Cook, Audrey ;

Elliott, Tony ;

Gale, Joanna ;

Gibbs, Stephanie ;

Graham, John D. ;

Hetherington, John ;

Hughes, Robert ;

Laing, Robert ;

McKinna, Fiona ;

McLaren, Duncan B. ;

O'Sullivan, Joe M. ;

Parikh, Omi ;

Peedell, Clive ;

Protheroe, Andrew ;

Robinson, Angus J. ;

Srihari, Narayanan ;

Srinivasan, Rajaguru ;

Staffurth, John ;

Sundar, Santhanam ;

Tolan, Shaun ;

Tsang, David ;

Wagstaff, John ;

Parmar, Mahesh K. B. .

LANCET, 2016, 387 (10024) :1163-1177

[9] Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy [J].

Ryan, Charles J. ;

Smith, Matthew R. ;

de Bono, Johann S. ;

Molina, Arturo ;

Logothetis, Christopher J. ;

de Souza, Paul ;

Fizazi, Karim ;

Mainwaring, Paul ;

Piulats, Josep M. ;

Ng, Siobhan ;

Carles, Joan ;

Mulders, Peter F. A. ;

Basch, Ethan ;

Small, Eric J. ;

Saad, Fred ;

Schrijvers, Dirk ;

Van Poppel, Hendrik ;

Mukherjee, Som D. ;

Suttmann, Henrik ;

Gerritsen, Winald R. ;

Flaig, Thomas W. ;

George, Daniel J. ;

Yu, Evan Y. ;

Efstathiou, Eleni ;

Pantuck, Allan ;

Winquist, Eric ;

Higano, Celestia S. ;

Taplin, Mary-Ellen ;

Park, Youn ;

Kheoh, Thian ;

Griffin, Thomas ;

Scher, Howard I. ;

Rathkopf, Dana E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (02) :138-148

[10] Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer [J].

Sweeney, Christopher J. ;

Chen, Yu-Hui ;

Carducci, Michael ;

Liu, Glenn ;

Jarrard, David F. ;

Eisenberger, Mario ;

Wong, Yu-Ning ;

Hahn, Noah ;

Kohli, Manish ;

Cooney, Matthew M. ;

Dreicer, Robert ;

Vogelzang, Nicholas J. ;

Picus, Joel ;

Shevrin, Daniel ;

Hussain, Maha ;

Garcia, Jorge A. ;

DiPaola, Robert S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (08) :737-746

← 1 2 →